These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 518800)

  • 21. Potentiation of the combination of pancuronium and metocurine by halothane and isoflurane in humans with and without renal failure.
    Bennett MJ; Hahn JF
    Anesthesiology; 1985 Jun; 62(6):759-64. PubMed ID: 4003796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased sensitivity to metocurine in patients with upper motoneuron disease.
    Shayevitz JR; Matteo RS
    Anesth Analg; 1985 Aug; 64(8):767-72. PubMed ID: 3160262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of pipecuronium and tubocurarine on plasma concentrations of histamine in humans.
    Naguib M; Abdulatif M; Absood A
    Br J Anaesth; 1991 Sep; 67(3):320-2. PubMed ID: 1654967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of metocurine during enflurance anesthesia in man.
    Stanley TH
    Anesth Analg; 1978; 57(5):540-3. PubMed ID: 568421
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemodynamic effects of metocurine during isoflurane anesthesia.
    Fyman PN; Hartung J; Casthely PA; Abrams LM; Schneider A; Weinberg S
    Acta Anaesthesiol Scand; 1986 Jan; 30(1):70-1. PubMed ID: 2938397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly.
    Matteo RS; Backus WW; McDaniel DD; Brotherton WP; Abraham R; Diaz J
    Anesth Analg; 1985 Jan; 64(1):23-9. PubMed ID: 3966648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of tubocurarine, gallamine and suxamethonium in dogs.
    Hughes R
    Br J Anaesth; 1970 Nov; 42(11):928-34. PubMed ID: 4098970
    [No Abstract]   [Full Text] [Related]  

  • 28. Metocurine kinetics in patients undergoing operations requiring cardiopulmonary bypass.
    Avram MJ; Shanks CA; Henthorn TK; Ronai AK; Kinzer J; Wilkinson CJ
    Clin Pharmacol Ther; 1987 Nov; 42(5):576-81. PubMed ID: 3315392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of neuromuscular blocking drugs on arterial pressure and heart rate in rats.
    Ertama PM; Paakkari I; Paakkari P; Karppanen H
    Med Biol; 1984; 62(4):231-8. PubMed ID: 6151034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical pharmacology of metocurine: dimethyltubocurarine revisited.
    Savarese JJ; Ali HH; Antonio RP
    Anesthesiology; 1977 Sep; 47(3):277-84. PubMed ID: 70179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of the neuromuscular effects of 3 curare-like agents in children].
    Nishan G; Goudsouzian NG; Mathieu A
    Ann Anesthesiol Fr; 1979; 20(4):286-92. PubMed ID: 40486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central cardiovascular actions of d-tubocurarine and inhibition of the hypotensive effect of clonidine.
    Tsoucaris-Kupfer D; Liblau L; Legrand M; Schmitt H
    Eur J Pharmacol; 1980 Jul; 65(2-3):301-4. PubMed ID: 7398793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of histamine liberation with atropine sulfate following administration of d-tubocurarine].
    Kubo K
    Anaesthesist; 1985 Oct; 34(10):502-7. PubMed ID: 2416236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metocurine requirements and plasma concentrations in burned paediatric patients.
    Martyn JA; Goudsouzian NG; Matteo RS; Liu LM; Szyfelbein SK; Kaplan RF
    Br J Anaesth; 1983 Apr; 55(4):263-8. PubMed ID: 6220728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals.
    Gronert GA; Fung DL; Jones JH; Shafer SL; Hildebrand SV; Disbrow EA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R85-91. PubMed ID: 7840343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease.
    Reich DL; Mulier J; Viby-Mogensen J; Konstadt SN; van Aken HK; Jensen FS; DePerio M; Buckley SG
    Can J Anaesth; 1998 Aug; 45(8):794-7. PubMed ID: 9793671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of atracurium, vecuronium, pancuronium and tubocurarine on renal sympathetic nerve activity in baroreceptor denervated dogs.
    Yoneda I; Goto H; Nishizawa M; Unruh GK; Arakawa K
    Br J Anaesth; 1994 Jun; 72(6):679-82. PubMed ID: 8024916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular, ventilatory and catecholamine responses to maximal dynamic exercise in partially curarized man.
    Galbo H; Kjaer M; Secher NH
    J Physiol; 1987 Aug; 389():557-68. PubMed ID: 3681737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting nondepolarizing neuromuscular blocking agents.
    Embree PB
    AANA J; 1993 Aug; 61(4):382-7. PubMed ID: 8397465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.
    Shafer SL; Varvel JR; Gronert GA
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):291-304. PubMed ID: 2810069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.